Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03565497 · ClinicalTrials.gov registry record · NA

Engaging Working Memory and Distress Tolerance to Aid Smoking Cessation

A NA study, sponsored by Boston University Charles River Campus.

Terminated
Registry status
NA
Development phase
30
Enrollment target

NCT03565497 is a NA study that was terminated before completion, run by Boston University Charles River Campus. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03565497, a NA study, was terminated before completion, sponsored by Boston University Charles River Campus.

TERMINATED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Specific Aims for this Project Are: 1. To evaluate the ability of two forms of mindfulness training, relative to a control intervention, to engage specific "triple-vulnerability" mechanistic targets that characterize low SES smokers. 1. The investigators hypothesize that both versions of the mindfulness training will show greater target engagement than the control treatment for mechanistic targets assessed under standard smoking conditions. 2. The investigators hypothesize that the enhanced mindfulness training, Mindfulness+IE, will show greater target engagement than the other two conditions for mechanistic targets assessed during the nicotine deprivation window. 2. To show that the hypothesized differential target engagement results in differential smoking self-control as evaluated by greater time to lapse, fewer cigarettes smoked, and different smoking topography in the McKee Lapse protocol. 3. To expand and refine the list of SOBC targets by showing the specific relationship between currently identified assays and empirically-validated alternative targets, with attention to showing which of the targeted mechanisms in which contexts are most linked to clinically-relevant outcomes assessed in the McKee protocol, and which offer redundant or non-significant prediction.

Interventions

  • BEHAVIORAL Mindfulness Training
  • BEHAVIORAL Wellness Education Control Condition
  • BEHAVIORAL Mindfulness Training Plus IE

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-04-19
Est. Completion 2021-08-31
Phase NA

What the Registry Record Tells You About NCT03565497

The ClinicalTrials.gov registry entry for NCT03565497 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Mindfulness Training is the first listed.

NCT03565497 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03565497 about?

NCT03565497 is a clinical study titled "Engaging Working Memory and Distress Tolerance to Aid Smoking Cessation". Specific Aims for this Project Are: 1. To evaluate the ability of two forms of mindfulness training, relative to a control intervention, to engage specific "triple-vulnerability" mechanistic targets that characterize low SES smokers. 1. The investigators hypothesize that both versions of the mi...

What is the current status of trial NCT03565497?

This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2019-04-19. Estimated completion is 2021-08-31.

What interventions are being tested in trial NCT03565497?

The interventions under investigation include: Mindfulness Training (BEHAVIORAL), Wellness Education Control Condition (BEHAVIORAL), Mindfulness Training Plus IE (BEHAVIORAL).

Who is sponsoring clinical trial NCT03565497?

This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.